Novogenia GmbH
Seed · 1 people tracked
Find your way into Novogenia GmbH
Sign up to see every warm intro you have to Novogenia GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novogenia GmbH team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Novogenia GmbH is a publicly traded biotech company working in genetics, personalization and AI. It also makes seed-stage investments internationally.
Team · 1 people
from public directoriesWhat they invest in
from 8 of 14 portfolio companiesBiotech ×5Digital Health ×5Healthtech ×5Wellness & Fitness ×4Consumer ×3Medical Devices ×2AI & Machine Learning ×1Data & Infrastructure ×1
HQs:Austria×4United States×3Germany×1
Investments · 14 tracked
founders shown can be your intro path305care sells premium skincare products developed in Düsseldorf, Germany, including personalized formulations based on individual skin factors as well as standardized items like serums, cleansers, and peelings.
ConsumerDirect to ConsumerWellness & FitnessDüsseldorf, DE
Genomelink develops a platform that provides individuals with access to and management of their genomic data, leveraging advances in DNA sequencing technology.
BiotechConsumerDigital HealthHealthtechWellness & FitnessSan Francisco, US
Tomohiro Takano(Founder)inKensuke Numakura(Founder)inTakamasa KudoYuta Matsudain
Co-investors500 GlobalBrighter CapitalCoral CapitalDG Daiwa VenturesLair East LabsLifeX Ventures+11 more
HLN-Genetik is a privately operated human genetics laboratory in Vienna offering reproductive genetics (preimplantation and polar body diagnostics, carrier and miscarriage testing) and human genetics analyses such as single-gene, panel, and exome testing.
BiotechDigital HealthHealthtechVienna, AT
Medicopharm is an Austrian company offering pharmaceuticals, medical devices, dietetic foods, and dietary supplements aimed at consumer health and well-being.
ConsumerE-commerceWellness & Fitness
Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases.
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical DevicesNew York City, US
Demetri Maxim(Founder and CEO)Vivek Bhalla(Chief Medical Officer)
Co-investorsChicago Early Growth Ventures (CEGV)StartXTechstarsY CombinatorZAKA VC10X Capital+14 more
NovoDaily is an Austrian biotech company that offers genetic testing, personalized supplements, and cosmetics along with lifestyle and nutrition recommendations based on an individual's genes, lifestyle, and goals.
BiotechDigital HealthWellness & Fitness
NovoMedic combines DNA analyses (micronutrient, fitness, pharmacogenetic, and prevention genetics) with personalized micronutrient formulations, offered to patients exclusively under physician supervision.
BiotechDigital HealthHealthtechSalzburg, AT
Spot provides white-label at-home diagnostic testing services for health brands, enabling users to collect and submit lab-analyzed blood, urine, and saliva samples at home.
Digital HealthHealthtechMedical DevicesSaaSCincinnati, US
Andrew Jajack(Founder)in
Co-investorsEntrepreneur FirstY CombinatorUnpopular Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ChirutecGeneplanetGenopediaInophaMendelioRevivme
Frequently asked questions
- How many investments has Novogenia GmbH made?
- Novogenia GmbH has 14 tracked investments.
- What stage does Novogenia GmbH invest at?
- Novogenia GmbH invests at the Seed stage.
- What sectors does Novogenia GmbH focus on?
- Novogenia GmbH focuses on Healthtech.
- Who does Novogenia GmbH co-invest with?
- Novogenia GmbH most often shares deals with Y Combinator, StartX, Entrepreneur First, among 15 tracked co-investors.
Similar investors
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
























